No Picture
Trading Ideas

Immunomedics Jumps Almost 30% In After-Hours On FDA Approval

Shares in biopharma Immunomedics (IMMU) soared 29% in Wednesday’s after-market trading following an early FDA approval for Trodelvy (sacituzumab govitecan) in triple-negative breast cancer. The drug is approved for patients who have already received two other lines of therapy for metastatic disease.The decision had been expected on the PDUFA date of June 2nd, so the announcement took investors and analysts by surprise.Previously, in January 2019, IMMU received a CRL (complete response letter) from the FDA on its first filing attempt seeking accelerated approval for the drug.“The issues related to approvability in the CRL were exclusively focused on Chemistry, Manufacturing and …read more […]

No Picture
Trading Ideas

Zoom Backlash Widens With Daimler, Ericsson and BofA Curbs

(Bloomberg) — Some of the world’s largest companies have advised against the use of Zoom Video Communications Inc.’s conferencing app, fueling a growing backlash against a service that shot to prominence during the Covid-19 pandemic.Daimler AG, Ericsson SA, NXP Semiconductors NV and Bank of America Corp. are among a wave of companies forbidding or warning employees against using Zoom because of concerns about its security, according to people familiar with their operations. They join corporations like Tesla Inc. and government agencies from Taiwan to Singapore that have banned the app’s use. India has deemed Zoom an unsafe platform and initiated …read more […]